Search Within

Katie Lynn Thoren

Formats
  1. Journal Article (22)
  2. Meeting Abstract (9)
  3. Review (5)
  4. Book Section (1)
Groups
  1. Department of Medicine (23)
  2. Center for Hematologic Malignancies (22)
  3. Hematologic Malignancies, Division of (22)
  4. Department of Pathology and Laboratory Medicine (20)
  5. Hematologic Malignancies Research (16)
  6. Myeloma (16)

More Groups

People
  1. Carl Landgren (15)
  2. Malin Hultcrantz (12)
  3. Mikhail Roshal (12)
  4. Alexander Lesokhin (11)
  5. Hani Hassoun (11)
  6. Kazunori Murata (11)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (9)
  4. 2020 (7)
  5. 2019 (11)
  6. 2018 (4)

More Years

Publications
  1. Blood (7)
  2. Journal of Applied Laboratory Medicine (5)
  3. Clinica Chimica Acta (3)
  4. Biology of Blood and Marrow Transplantation (2)
  5. JAMA Oncology (2)
  6. Best Practice and Research: Clinical Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Amer Assoc Clinical Chemistry (5)
  3. Elsevier Inc. (5)
  4. Elsevier Science BV (3)
  5. American Association for Clinical Chemistry (2)
  6. American Medical Association (2)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Isatuximab-specific immunofixation electrophoresis assay to remove interference in serum M-protein measurement in patients with multiple myeloma
    Journal Article

    Thoren, K.; Menad, S.; Nouadje, G.; MaceĢ, S.
    Journal of Applied Laboratory Medicine (2024)

    Fulltext@MSK | Save
  • Monoclonal gammopathy detection and current technologies
    Book Section

    Hutcherson, S. M.; Thoren, K. L.
    In Ramanathan, L. V.; Fleisher, M.; Duffy, M. J. (Eds.) Cancer Biomarkers: Clinical Aspects and Laboratory Determination (2022)

    Fulltext@MSK | Save
  • Use of a daratumumab-specific immunofixation assay to assess possible immunotherapy interference at a major cancer center: Our experience and recommendations
    Journal Article

    Kirchhoff, D. C.; Murata, K.; Thoren, K. L.
    Journal of Applied Laboratory Medicine (2021)

    Fulltext@MSK | Save
  • Immunotyping provides equivalent results to immunofixation in a population with a high prevalence of monoclonal gammopathies
    Journal Article

    Thoren, K. L.; McCash, S. I.; Murata, K.
    Journal of Applied Laboratory Medicine (2021)

    Fulltext@MSK | Save
  • Minimal residual disease in myeloma: Application for clinical care and new drug registration
    Review

    Anderson, K. C.; Auclair, D.; Adam, S. J.; Agarwal, A.; Anderson, M.; Avet-Loiseau, H.; Bustoros, M.; Chapman, J.; Connors, D. E.; Dash, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Minimal residual disease in multiple myeloma: Defining the role of next generation sequencing and flow cytometry in routine diagnostic use
    Review

    Maclachlan, K. H.; Came, N.; Diamond, B.; Roshal, M.; Ho, C.; Thoren, K.; Mayerhoefer, M. E.; Landgren, O.; Harrison, S.
    Pathology (2021)

    Fulltext@MSK | Save
  • Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
    Review

    Diamond, B. T.; Rustad, E.; Maclachlan, K.; Thoren, K.; Ho, C.; Roshal, M.; Ulaner, G. A.; Landgren, C. O.
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • Lifetime pesticide use and monoclonal gammopathy of undetermined significance in a prospective cohort of male farmers
    Journal Article

    Hofmann, J. N.; Beane Freeman, L. E.; Murata, K.; Andreotti, G.; Shearer, J. J.; Thoren, K.; Ramanathan, L.; Parks, C. G.; Koutros, S.; Lerro, C. C.; more...
    Environmental Health Perspectives (2021)

    Fulltext@MSK | Save